PCV76 COMTEMPORARY HEART FAILURE TREATMENT PATTERN AND COST IN CHINESE PATIENTS POPULATIONS.

In China, very few studies on HF treatment pattern and associated costs have been done to understand HF patients' disease burden and unmet medical needs. HF treatment cost had increased by 15% from 2014-2017, and hospitalization is the most dominant cost driver. The study showed significant disease economic burden to HF patients and thus strong unmet medical need to reduce HF hospitalization and improve guideline adherence in China. [Extracted from the article]